IL-22 is pathogenic in psoriasis and protective in inflammatory bowel disease, hepatitis, Klebsiella pneumonia, myocarditis, ulcerative colitis, airway inflammation and autoimmune allergic asthma [3], [4], [5], [6], [7], [8], [9], [10], [11], [12]. This evidence concerns the gene IL22 and psoriasis.